Literature DB >> 22918707

A key role for nuclear cardiac imaging in evaluating and managing patients with heart failure.

Mark I Travin, Gayathri Kamalakkannan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918707     DOI: 10.1007/s12350-012-9615-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  41 in total

Review 1.  Radionuclide imaging of cardiac autonomic innervation.

Authors:  Sang Yong Ji; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

2.  Estimates of implantable cardioverter-defibrillator complications: caveat emptor.

Authors:  Kelley P Anderson
Journal:  Circulation       Date:  2009-03-03       Impact factor: 29.690

3.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Non-evidence-based ICD implantations in the United States.

Authors:  Sana M Al-Khatib; Anne Hellkamp; Jeptha Curtis; Daniel Mark; Eric Peterson; Gillian D Sanders; Paul A Heidenreich; Adrian F Hernandez; Lesley H Curtis; Stephen Hammill
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

6.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

7.  Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement.

Authors:  Eric S Ketchum; Alec J Moorman; Daniel P Fishbein; Nahush A Mokadam; Edward D Verrier; Gabriel S Aldea; Shauna Andrus; Kenneth W Kenyon; Wayne C Levy
Journal:  J Heart Lung Transplant       Date:  2010-06-16       Impact factor: 10.247

8.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

9.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

10.  Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

Authors:  Alfred E Buxton; Kerry L Lee; Gail E Hafley; Luis A Pires; John D Fisher; Michael R Gold; Mark E Josephson; Michael H Lehmann; Eric N Prystowsky
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.